Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022
- PMID: 36682773
- PMCID: PMC10164595
- DOI: 10.5551/jat.CR005
Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022
Keywords: Adults; Diagnostic criteria; Familial Hypercholesterolemia; Heterozygote; Homozygote; LDL apheresis; Lifestyle; Pharmacological therapy; Statins; Treatment guidelines.
Conflict of interest statement
The following discloses the conflicts of interest of the members of the Working Group of the Japan Atherosclerosis Society for the Development of Guidelines for the Treatment of Adult Familial Hypercholesterolemia for the years 2017 - 2021.
Figures
References
-
- Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, Tada H, Nakanishi C, Mori M, Yamagishi M, Inazu A, Koizumi J: Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis, 2011; 214: 404-407 - PubMed
-
- Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG: Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects. J Am Coll Cardiol, 2020; 75: 2553-2566 - PubMed
